Frequently Asked Questions

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (5191)

Sunday, 08 August 2021 11:19

David Vulkan

Written by
Sunday, 08 August 2021 11:19

John K Field

Written by
Professor John K Field PhD, FRCPath.

Director of Research, Roy Castle Lung Cancer Research Programme
The University of Liverpool
Department of Molecular and Clinical Cancer Medicine
Institute of Systems, Molecular & Integrative Biology
The William Duncan Building
6 West Derby Street, L7 8TX
LIVERPOOL, UK.

Email This email address is being protected from spambots. You need JavaScript enabled to view it.

Short Biography

Professor John Field has a Personal Clinical Chair in Molecular Oncology at the University of Liverpool. He is the Chief Investigator for the UK Lung Cancer Screening Trial (UKLS) and the principal investigator of the Liverpool Lung Project (LLP), a 21year molecular- epidemiological study into the early detection of lung cancer (~14,000 recruited). Development of Lung cancer risk prediction model, which have been used in the UKLS and National lung cancer screening implementation programmes. The UKLS and the LLP form part of the NCRI Lung Cancer portfolio. Currently co-applicant on the NIH U19 programme grant involving biomarkers, radiomics and risk-modelling; contributing to the lung cancer genetic susceptibility projects ‘Lung Oncoarray’ project with CIDR/USA. Also, long term involvement in the identification of molecular diagnostic markers in lung cancers; currently a major programme funded by Janssen.
His research funding has been provided mainly by the RCF, NWCRF, MRC, CRUK, EU, NIH HTA and Pharma.

https://www.liverpool.ac.uk/translational-medicine/staff/john-field/
https://liverpoollungproject.org.uk/
http://www.ukls.org/
https://orcid.org/0000-0003-3951-6365
Sunday, 08 August 2021 11:19

Stephen Lam

Written by
Sunday, 08 August 2021 11:19

Kwun Fong

Written by
Sunday, 08 August 2021 11:19

Samuel Janes

Written by
Sunday, 08 August 2021 11:19

David Lam

Written by
Sunday, 08 August 2021 11:19

Christine Dorothy Berg

Written by
Christine D. Berg, M.D. currently serves as a Special Volunteer to the Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. She is an advisor to GRAIL, Inc https://grail.com/ and a consultant to Mercy Bioanalytics https://mercybio.com/ . Her research efforts focus on cancer risk-based assessment and how to integrate molecular epidemiology and then move these efforts into the clinical arena. She is the former Chief, Early Detection Research Group, Division of Cancer Prevention, National Cancer Institute. In this position, she was Project Officer for the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and the National Lung Screening Trial (NLST). She previously worked at Suburban Hospital as the Cancer Center Director and at the Georgetown University Medical School Lombardi Cancer Center as the head of breast cancer radiation oncology and as director of the residency training program. She attended Northwestern University in the Honors Program in Medical Education receiving her B.S. and M.D. in six years. She is board certified in Internal Medicine, Medical Oncology and Radiation Oncology.
Additional activities focus on adaptation and mitigation of the public health effects of the climate crisis. She serves on the Board of Public Employees for Environmental Responsibility www.peer.org She is a member of the Climate Victory Council of the League of Conservation Voters and volunteers for the Sierra Club and Elders Climate Action. She has recently joined the Cosmos Club https://www.cosmosclub.org/ in Washington DC where she participates actively in the Climate Change Group and the Natural Resources Group.
Sunday, 08 August 2021 11:19

John Mayo

Written by
Sunday, 08 August 2021 11:19

John Yee

Written by
Sunday, 08 August 2021 11:19

Maryanne Weber

Written by
Page 218 of 371